Literature DB >> 16873686

alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet.

Xianwen Yi1, Nobuyo Maeda.   

Abstract

Considerable evidence indicates that hyperglycemia increases oxidative stress and contributes to the increased incidence of atherosclerosis and cardiovascular complications in diabetic patients. To examine the effect of alpha-lipoic acid, a potent natural antioxidant, on atherosclerosis in diabetic mice, 3-month-old apolipoprotein (apo) E-deficient (apoE(-/-)) mice were made diabetic by administering streptozotocin (STZ). At 4 weeks after starting the STZ administration, a high-fat diet with or without alpha-lipoic acid (1.65 g/kg) was given to the mice and to nondiabetic apoE(-/-) controls. At 20 weeks, markers of oxidative stress were significantly lower in both the diabetic apoE(-/-) mice and their nondiabetic apoE(-/-) controls with alpha-lipoic acid supplement than in those without it. Remarkably, alpha-lipoic acid completely prevented the increase in plasma total cholesterol, atherosclerotic lesions, and the general deterioration of health caused by diabetes. These protective effects of alpha-lipoic acid were accompanied by a reduction of plasma glucose and an accelerated recovery of insulin-producing cells in the pancreas, suggesting that part of its effects are attributable to protecting pancreatic beta-cells from damage. Our results suggest that dietary alpha-lipoic acid is a promising protective agent for reducing cardiovascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873686     DOI: 10.2337/db06-0251

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  34 in total

1.  Alpha-lipoic acid preserves the structural and functional integrity of red blood cells by adjusting the redox disturbance and decreasing O-GlcNAc modifications of antioxidant enzymes and heat shock proteins in diabetic rats.

Authors:  Mihailović Mirjana; Arambašić Jelena; Uskoković Aleksandra; Dinić Svetlana; Grdović Nevena; Marković Jelena; Poznanović Goran; Vidaković Melita
Journal:  Eur J Nutr       Date:  2011-11-18       Impact factor: 5.614

2.  Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway.

Authors:  Woo-Ram Lee; Aekyong Kim; Kee-Sik Kim; Yoon-Yub Park; Ji-Hyun Park; Kyung-Hyun Kim; Soo-Jung Kim; Kwan-Kyu Park
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

3.  Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Kuikwon Kim; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2010-03-10       Impact factor: 5.162

4.  Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet.

Authors:  F Li; C-H Wang; J-G Wang; T Thai; G Boysen; L Xu; A L Turner; A S Wolberg; N Mackman; N Maeda; N Takahashi
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

5.  Lipoic acid attenuates innate immune infiltration and activation in the visceral adipose tissue of obese insulin resistant mice.

Authors:  J A Deiuliis; T Kampfrath; Z Ying; A Maiseyeu; S Rajagopalan
Journal:  Lipids       Date:  2011-08-23       Impact factor: 1.880

6.  Physiological activities of the combination of fish oil and α-lipoic acid affecting hepatic lipogenesis and parameters related to oxidative stress in rats.

Authors:  Takashi Ide
Journal:  Eur J Nutr       Date:  2017-03-20       Impact factor: 5.614

7.  Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.

Authors:  X Du; D Edelstein; M Brownlee
Journal:  Diabetologia       Date:  2008-07-29       Impact factor: 10.122

8.  New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis.

Authors:  Shaomin Tian; Jun Nakamura; Sylvia Hiller; Stephen Simington; Darcy W Holley; Roberto Mota; Monte S Willis; Scott J Bultman; J Christopher Luft; Joseph M DeSimone; Zhenquan Jia; Nobuyo Maeda; Xianwen Yi
Journal:  Vascul Pharmacol       Date:  2020-08-01       Impact factor: 5.773

9.  Alpha-lipoic acid induces elevated S-adenosylhomocysteine and depletes S-adenosylmethionine.

Authors:  Sally P Stabler; Jeevan Sekhar; Robert H Allen; Heidi C O'Neill; Carl W White
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

Review 10.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

Authors:  William I Sivitz; Mark A Yorek
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.